LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis

Xia Chen1, Jingxiu Yang1, Yuping Wang1

  • 1Department of Gynaecology and Obstetrics, The Affiliated Lianyungang Oriental Hospital of Xuzhou Medical University, No. 57 Zhong'hua Rest Road, Lianyun District, Lianyungang, 222042 Jiangsu China.

Cancer Cell International
|September 18, 2020
PubMed
Abstract

Insights

The long noncoding RNA JPX promotes cervical cancer by regulating miR-25-3p and SOX4. This finding suggests JPX as a potential therapeutic target for cervical cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) are implicated in tumor development.
  • The role of lncRNA JPX in cervical cancer (CC) is currently unknown.
  • JPX acts as a molecular switch for X-chromosome inactivation.

Purpose of the Study:

  • To investigate the functional role and mechanism of lncRNA JPX in cervical cancer.
  • To explore the relationship between JPX, miR-25-3p, and SOX4 in CC.
  • To determine if the JPX/miR-25-3p/SOX4 axis is a potential therapeutic target for CC.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and western blotting assessed JPX, miR-25-3p, and SOX4 expression.
  • Bioinformatic analysis (StarBase v2.0), luciferase reporter, and RNA immunoprecipitation assays investigated the JPX-miR-25-3p interaction.
  • Cell proliferation, migration, and invasion were evaluated using EdU, CCK-8, and Transwell assays.
  • In vivo tumor xenograft assays in nude mice demonstrated the axis's role in CC progression.

Main Results:

  • JPX was significantly upregulated, while miR-25-3p was downregulated in CC tissues and cell lines.
  • JPX overexpression enhanced, and knockdown inhibited, HeLa cell proliferation, migration, and invasion.
  • JPX knockdown suppressed HeLa cell viability and tumor growth by upregulating miR-25-3p and downregulating SOX4.
  • JPX expression negatively correlated with miR-25-3p in CC tissues.

Conclusions:

  • lncRNA JPX promotes cervical cancer progression by modulating the miR-25-3p/SOX4 axis.
  • The JPX/miR-25-3p/SOX4 pathway represents a potential therapeutic target for cervical cancer.
  • Understanding lncRNA JPX's mechanism offers insights into cervical cancer development.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K